Treatment of inflamed pterygium and pinguecula with topical indomethacin 0.1% solution. Cornea 1997;16:42- 47.Frucht-Pery J,Solomon A,Siganos CS. Treatment of inflamed pterygium and pinguecula with topical indomethacin 0.1% solution[J].Cornea,1997,(1):42-47....
Fellow eyes also had abnormalities of the tear film function, and nearly 50% of these eyes had uninflamed pinguecula (40%) or pterygium (9%). Corneal Epithelial Damage and Impaired Tear Functions in Patients with Inflamed Pinguecula In the case of the control group, samples were taken from ...
AIMS: To describe the use of subconjunctival bevacizumab or ranibizumab, an approved antivascular endothelial growth factor for wet macular degeneration, in halting the inflammation of a pterygium or a partially excised pterygium. METHODS: Case reports. RESULTS: Prompt regression of conjunctival micro...
PURPOSE: To compare the effect of topical indomethacin 0.1% solution with the effect of topical dexamethasone 0.1% phosphate solution on signs and symptoms of inflamed pterygium and pinguecula. METHODS: Of 50 consecutive patients who had inflamed pterygia (n = 17) or pingueculae (n = 33), met...
inflamed pterygiumrecurrent pterygiumvascular endothelial growth factorziv-afliberceptPurpose: Intralesional single low-dose vascular endothelial growth factor antagonists have traditionally failed in causing regression of pterygia. The current pilot study in...